Acceleron Pharma Inc. (XLRN): Price and Financial Metrics
XLRN Price/Volume Stats
| Current price | $178.75 | 52-week high | $189.99 |
| Prev. close | $179.68 | 52-week low | $108.82 |
| Day low | $177.06 | Volume | 7,884,200 |
| Day high | $179.85 | Avg. volume | 572,759 |
| 50-day MA | $168.57 | Dividend yield | N/A |
| 200-day MA | $137.67 | Market Cap | 10.93B |
XLRN Stock Price Chart Interactive Chart >
Acceleron Pharma Inc. (XLRN) Company Bio
Acceleron Pharma XLRN is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases. The company was founded in 2003 and is based in Cambridge, Massachusetts.
XLRN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 302.86% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 141.31% |
| 2019 | 21.75% |
Continue Researching XLRN
Here are a few links from around the web to help you further your research on Acceleron Pharma Inc's stock as an investment opportunity:Acceleron Pharma Inc (XLRN) Stock Price | Nasdaq
Acceleron Pharma Inc (XLRN) Stock Quote, History and News - Yahoo Finance
Acceleron Pharma Inc (XLRN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...